Hydroxamate-Based Selective Macrophage Elastase (Mmp-12) Inhibitors And Radiotracers For Molecular Imaging

Macrophage elastase [matrix metalloproteinase (MMP)-12] is the most upregulated MMP in abdominal aortic aneurysm (AAA) and, hence, MMP-12-targeted imaging may predict AAA progression and rupture risk. Here, we report the design, synthesis, and evaluation of three novel hydroxamate-based selective MMP-12 inhibitors (CGA, CGA-1, and AGA) and the methodology to obtain MMP-12 selectivity from hydroxamate-based panMMP inhibitors. Also, we report two Tc-99m-radiotracers, Tc-99m-AGA-1 and Tc-99m-AGA-2, derived from AGA. Tc-99m-AGA-2 displayed faster blood clearance in mice and better radiochemical stability compared to Tc-99m-AGA-1. Based on this, Tc-99m-AGA-2 was chosen as the lead tracer and tested in murine AAA. Tc-99m-AGA-2 uptake detected by autoradiography was significantly higher in AAA compared to normal aortic regions. Specific binding of the tracer to MMP-12 was demonstrated through ex vivo competition. Accordingly, this study introduces a novel family of selective MMP-12 inhibitors and tracers, paving the way for further development of these agents as therapeutic and imaging agents.